Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 11/20 | 0.58 |
| ▸ | MAOA | P21397 | 7/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL19742209 | 0.98 | CA12 (0.56) | CA12CA1CA2CA4CA7 | |
| SCHEMBL20530610 | 0.94 | MAOB (0.62) | CA12CA1CA2CA4CA7 | |
| SCHEMBL5704167 | 0.88 | CA12 (0.63) | CA12CA1CA2CA4CA7 | |
| Hydrochloric Acid SCHEMBL21694040 | 0.85 | CA12 (0.61) | CA12CA1CA2CA4CA7 | |
| SCHEMBL20530611 | 0.82 | MAOB (0.54) | CA12CA1CA2CA4CA7 | |
| SCHEMBL15800551 | 0.81 | CA12 (0.57) | CA12CA1CA2CA4CA7 | |
| SCHEMBL9155218 | 0.81 | GSTP1 (0.68) | CA12CA1CA2CA4CA7 | |
| SCHEMBL14645171 | 0.81 | APP (0.57) | CA12CA1CA2CA4CA7 | |
| SCHEMBL31691312 | 0.80 | ALDH1A1 (0.65) | CA12CA1CA2CA4CA7 | |
| SCHEMBL18844813 | 0.79 | TAAR1 (0.52) | CA12CA1CA2CA4CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707842-A | Proteome targeting labeling capture probe and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2025-03-28 | — | — | CN | claimed |
| CN-118307780-A | Polyimide toughening agent and preparation method and application thereof | 中国科学院化学研究所 | 2024-07-09 | — | — | CN | claimed |
| CN-111116950-B | High-performance polyimide film and preparation method thereof | 株洲时代华鑫新材料技术有限公司 | 2022-08-23 | — | — | CN | claimed |
| CN-114752337-A | Waterproof MS sealant and preparation method thereof | 江苏瑞洋安泰新材料科技有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-108752594-B | Amphipathic block polymer based on azo reductase response and preparation method and application thereof | 苏州大学张家港工业技术研究院 | 2020-09-25 | — | — | CN | claimed |
| CN-111116950-A | High-performance polyimide film and preparation method thereof | 株洲时代华鑫新材料技术有限公司 | 2020-05-08 | — | — | CN | claimed |
| EP-2611797-B1 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | HANMI SCIENCE CO LTD (KR) | 2016-12-28 | — | — | EP | claimed |
| US-9147603-B2 | Polymer grafting for enhanced dielectric and interconnect material adhesion | INTEL CORPORATION (US) | 2015-09-29 | — | — | US | claimed |
| US-20150206793-A1 | POLYMER GRAFTING FOR ENHANCED DIELECTRIC AND INTERCONNECT MATERIAL ADHESION | INTEL CORPORATION | 2015-07-23 | — | — | US | claimed |
| US-8835458-B2 | Quinoline or quinazoline derivatives with apoptosis inducing activity on cells | HANMI SCIENCE CO., LTD (KR) | 2014-09-16 | — | — | US | claimed |
| EP-2611797-A2 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | Hanmi Science Co., Ltd. (KR) | 2013-07-10 | — | — | EP | claimed |
| US-20130165386-A1 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | HANMI SCIENCE CO., LTD (KR) | 2013-06-27 | — | — | US | claimed |
| WO-2012030160-A2 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | HANMI HOLDINGS CO., LTD. (KR) | 2012-03-08 | — | — | WO | claimed |
| CN-100554251-C | A kind of maleimide derivatives and preparation method thereof | CHINESE ACAD INST CHEMISTRY (CN) | 2009-10-28 | — | — | CN | claimed |
| CN-1896058-A | Maleimide derivative and its preparation | CHINESE ACAD INST CHEMISTRY (CN) | 2007-01-17 | — | — | CN | claimed |
| EP-4676926-A1 | BICYCLIC HETEROARYL COMPOUNDS FOR USE AS GPR35 MODULATORS | ThirtyFiveBio Limited (GB) | 2026-01-14 | — | — | EP | disclosed |
| WO-2025096924-A2 | METHODS OF LABELING, PROCESSING, AND ANALYZING PROTEIN SAMPLES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-05-08 | — | — | WO | disclosed |
| US-6573269-B1 | Compounds for protecting surface of substrate from ultraviolet light | ROCHE VITAMINS INC. | 2003-06-03 | — | — | US | disclosed |
| EP-1081140-A2 | Novel Pyrimidine-2,4,6-trione compounds | F. HOFFMANN-LA ROCHE AG (CH) | 2001-03-07 | — | — | EP | disclosed |
| US-3978091-A | FUNGICIDES, INSECTICIDES, NEMATOCIDES | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JA) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165386-A1 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | CASP7, API5, BAX | CA12 3044/4885CA1 409/4885CA2 501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.